Search

Your search keyword '"Goate, Alison"' showing total 3,122 results

Search Constraints

Start Over You searched for: Author "Goate, Alison" Remove constraint Author: "Goate, Alison"
3,122 results on '"Goate, Alison"'

Search Results

51. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease

52. New insights into the genetic etiology of Alzheimer’s disease and related dementias

53. Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease

54. Discovery and validation of dominantly inherited Alzheimer’s disease mutations in populations from Latin America

55. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study

56. Missense and loss‐of‐function variants at GWAS loci in familial Alzheimer's disease.

57. Widespread transposable element dysregulation in human aging brains with Alzheimer's disease.

58. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study

60. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease

61. Analysis of shared heritability in common disorders of the brain

62. Analysis of shared heritability in common disorders of the brain.

63. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease

64. CYP2A6 metabolism in the development of smoking behaviors in young adults

65. Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study

66. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging

67. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease

68. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson’s disease myeloid cells

69. A genome-wide association study of interhemispheric theta EEG coherence: implications for neural connectivity and alcohol use behavior

71. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study

72. Transethnic genome‐wide scan identifies novel Alzheimer's disease loci

73. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score

74. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

75. Human whole-exome genotype data for Alzheimer’s disease

76. Allele-specific expression and high-throughput reporter assay reveal functional genetic variants associated with alcohol use disorders

77. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

79. Upregulated GIRK2 counteracts ethanol-induced changes in excitability & respiration in human neurons

80. Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

81. Novel avenues of tau research

82. The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer’s disease

83. ABCA7 frameshift deletion associated with Alzheimer disease in African Americans

84. Assessment of the genetic variance of late-onset Alzheimer's disease

85. Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits

86. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin

87. Alzheimer’s Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci

88. Identification of Rare Damaging Missense and Loss of Function Variants in GWAS Loci Using Genome Sequencing Data from Two Cohorts of Familial Late-Onset Alzheimer's Disease

89. Anti‐MS4A4A Antibody Modulates Myeloid Cell Biology and TREM2 Signaling

91. Evaluating brain age as a marker of autosomal dominant Alzheimer disease progression

92. Phospholipase D3 drives microglial response to amyloid pathology in Alzheimer’s disease

95. Refinement of Neurofilament light Dynamics in CSF and Blood for familial Alzheimer’s Disease

Catalog

Books, media, physical & digital resources